<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Carenity Pro</title>
	<atom:link href="https://pro.carenity.com/feed/" rel="self" type="application/rss+xml" />
	<link>https://pro.carenity.com/</link>
	<description>Carenity solutions for professionels</description>
	<lastBuildDate>Mon, 17 Aug 2026 15:39:40 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.6.7</generator>
	<item>
		<title>Are We Underestimating the True Cost of Productivity Loss?</title>
		<link>https://pro.carenity.com/2026/08/13/are-we-underestimating-the-true-cost-of-productivity-loss/</link>
					<comments>https://pro.carenity.com/2026/08/13/are-we-underestimating-the-true-cost-of-productivity-loss/#respond</comments>
		
		<dc:creator><![CDATA[Carenity Team]]></dc:creator>
		<pubDate>Thu, 13 Aug 2026 07:16:33 +0000</pubDate>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[carenity]]></category>
		<category><![CDATA[evidentiq]]></category>
		<guid isPermaLink="false">https://pro.carenity.com/?p=25231</guid>

					<description><![CDATA[<p>Download Infographic   When evaluating the economic burden of disease, productivity loss is an important part of the equation. But are we capturing all of it? Traditional approaches often rely on administrative data such as sick leave and disability. These measures tell us when patients are absent from work — but they can miss ...</p>
<p>The post <a href="https://pro.carenity.com/2026/08/13/are-we-underestimating-the-true-cost-of-productivity-loss/">Are We Underestimating the True Cost of Productivity Loss?</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><div class="fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="background-color: rgba(255,255,255,0);background-position: left top;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last" style="margin-top:0px;margin-bottom:30px;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy" style="background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0 0 0 0;border-color:#dddddd;border-style:solid;padding: 0px 0px 0px 0px;"><div class="fusion-column-content-centered"><div class="fusion-column-content"><div class="fusion-align-block"><style>.fusion-body .fusion-button.button-1{border-radius:0px 0px 0px 0px;}</style><a class="fusion-button button-flat fusion-button-default-size button-default button-1 fusion-button-default-span fusion-button-default-type" target="_self" href="#" data-toggle="modal" data-target=".fusion-modal.form-infographic-productivite" style="width:calc(100%);"><span class="fusion-button-text">Download Infographic</span></a></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;width:100%;"><div class="fusion-separator-border sep-double sep-dotted" style="border-color:#e0dede;border-top-width:1px;border-bottom-width:1px;"></div></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-1 fusion-text-no-margin" style="text-align:justify;margin-top:30px;margin-bottom:20px;"><p class="isSelectedEnd">When evaluating the economic burden of disease, productivity loss is an important part of the equation. But are we capturing all of it?</p>
<p class="isSelectedEnd">Traditional approaches often rely on administrative data such as <strong>sick leave and disability</strong>. These measures tell us when patients are absent from work — but they can miss what happens when patients <strong>continue working while their health affects their ability to perform at their usual capacity</strong>.</p>
<p class="isSelectedEnd">This less visible burden, known as <strong>presenteeism</strong>, can be particularly relevant for people living with chronic or fluctuating conditions. Fatigue, pain, cognitive difficulties or disease flares may affect productivity without necessarily resulting in a day off work.</p>
<p class="isSelectedEnd">And the impact can extend even further.</p>
<p class="isSelectedEnd">Reduced working hours, career interruptions, delayed education or changes in professional roles can all contribute to the broader economic burden of disease — yet these consequences may be difficult to capture through medico-administrative databases alone.</p>
<h3><span style="color: #06c1a6;"><strong>When patient-reported data can make the difference</strong></span></h3>
<p class="isSelectedEnd">Patient-reported data can complement traditional sources by providing a more granular picture of how disease affects patients&#8217; professional and daily lives.</p>
<p class="isSelectedEnd">They can help researchers capture not only <strong>absenteeism</strong>, but also:</p>
<ul>
<li style="list-style-type: none;">
<ul>
<li>Presenteeism and overall work impairment</li>
<li>Functional limitations while working</li>
<li>Changes in employment or working hours</li>
<li>Variations in productivity over time</li>
<li>Longer-term impacts on education, career and family decisions</li>
</ul>
</li>
</ul>
<p class="isSelectedEnd">This becomes particularly important in chronic and fluctuating conditions, rare diseases, early-onset diseases and populations for which traditional data sources may be limited or fragmented.</p>
<h3><strong><span style="color: #06c1a6;">From productivity loss to economic burden</span></strong></h3>
<p class="isSelectedEnd">Capturing these experiences is only the first step.</p>
<p class="isSelectedEnd"><strong>Which instruments should researchers use? How can patient-reported productivity loss be translated into economic costs? And how can methodological choices affect the results of an HEOR model?</strong></p>
<p class="isSelectedEnd">The answers matter because productivity loss is not a single concept. What researchers measure, the data they use and how they assign an economic value to that loss can lead to very different estimates of disease burden.</p>
<p class="isSelectedEnd">Our whitepaper, <strong>“When, how and why should we assess productivity loss using patient-reported data?”</strong>, explores these questions in more detail, including:</p>
<ul>
<li style="list-style-type: none;">
<ul>
<li>When patient-reported data are particularly valuable for cost modelling</li>
<li>The instruments available to measure productivity loss</li>
<li>Approaches for translating productivity impairment into economic costs</li>
<li>The limitations researchers should consider</li>
<li>Why these methodological choices matter for HEOR models</li>
</ul>
</li>
</ul>
<h3><span style="color: #06c1a6;"><strong>Want to explore the methodology?</strong></span></h3>
<p><strong>Download the full infographic to discover when and how patient-reported data can strengthen productivity-loss assessment in HEOR.</strong></p>
</div><div class="fusion-align-block"><style>.fusion-body .fusion-button.button-2{border-radius:0px 0px 0px 0px;}</style><a class="fusion-button button-flat fusion-button-default-size button-default button-2 fusion-button-default-span fusion-button-default-type" target="_self" href="#" data-toggle="modal" data-target=".fusion-modal.form-infographic-productivite" style="width:calc(100%);"><span class="fusion-button-text">Learn more: Download Infographic</span></a></div><div class="fusion-modal modal fade modal-1 form-infographic-productivite" tabindex="-1" role="dialog" aria-labelledby="modal-heading-1" aria-hidden="true"><style type="text/css">.modal-1 .modal-header, .modal-1 .modal-footer{border-color:#ebebeb;}</style><div class="modal-dialog modal-lg" role="document"><div class="modal-content fusion-modal-content" style="background-color:#f6f6f6"><div class="modal-header"><button class="close" type="button" data-dismiss="modal" aria-hidden="true" aria-label="Close">&times;</button><h3 class="modal-title" id="modal-heading-1" data-dismiss="modal" aria-hidden="true"></h3></div><div class="modal-body fusion-clearfix"><strong style="font-size: 20px;">Download the infographic</strong></p>
<p>&nbsp;</p>
<p>Discover the hidden costs of productivity loss linked to illness.</p>
<p>&nbsp;</p>
<script type="text/javascript">
/* <![CDATA[ */
var gform;gform||(document.addEventListener("gform_main_scripts_loaded",function(){gform.scriptsLoaded=!0}),document.addEventListener("gform/theme/scripts_loaded",function(){gform.themeScriptsLoaded=!0}),window.addEventListener("DOMContentLoaded",function(){gform.domLoaded=!0}),gform={domLoaded:!1,scriptsLoaded:!1,themeScriptsLoaded:!1,isFormEditor:()=>"function"==typeof InitializeEditor,callIfLoaded:function(o){return!(!gform.domLoaded||!gform.scriptsLoaded||!gform.themeScriptsLoaded&&!gform.isFormEditor()||(gform.isFormEditor()&&console.warn("The use of gform.initializeOnLoaded() is deprecated in the form editor context and will be removed in Gravity Forms 3.1."),o(),0))},initializeOnLoaded:function(o){gform.callIfLoaded(o)||(document.addEventListener("gform_main_scripts_loaded",()=>{gform.scriptsLoaded=!0,gform.callIfLoaded(o)}),document.addEventListener("gform/theme/scripts_loaded",()=>{gform.themeScriptsLoaded=!0,gform.callIfLoaded(o)}),window.addEventListener("DOMContentLoaded",()=>{gform.domLoaded=!0,gform.callIfLoaded(o)}))},hooks:{action:{},filter:{}},addAction:function(o,r,e,t){gform.addHook("action",o,r,e,t)},addFilter:function(o,r,e,t){gform.addHook("filter",o,r,e,t)},doAction:function(o){gform.doHook("action",o,arguments)},applyFilters:function(o){return gform.doHook("filter",o,arguments)},removeAction:function(o,r){gform.removeHook("action",o,r)},removeFilter:function(o,r,e){gform.removeHook("filter",o,r,e)},addHook:function(o,r,e,t,n){null==gform.hooks[o][r]&&(gform.hooks[o][r]=[]);var d=gform.hooks[o][r];null==n&&(n=r+"_"+d.length),gform.hooks[o][r].push({tag:n,callable:e,priority:t=null==t?10:t})},doHook:function(r,o,e){var t;if(e=Array.prototype.slice.call(e,1),null!=gform.hooks[r][o]&&((o=gform.hooks[r][o]).sort(function(o,r){return o.priority-r.priority}),o.forEach(function(o){"function"!=typeof(t=o.callable)&&(t=window[t]),"action"==r?t.apply(null,e):e[0]=t.apply(null,e)})),"filter"==r)return e[0]},removeHook:function(o,r,t,n){var e;null!=gform.hooks[o][r]&&(e=(e=gform.hooks[o][r]).filter(function(o,r,e){return!!(null!=n&&n!=o.tag||null!=t&&t!=o.priority)}),gform.hooks[o][r]=e)}});
/* ]]&gt; */
</script>

                <div class='gf_browser_gecko gform_wrapper gravity-theme gform-theme--no-framework' data-form-theme='gravity-theme' data-form-index='0' id='gform_wrapper_4' ><div id='gf_4' class='gform_anchor' tabindex='-1'></div><form method='post' enctype='multipart/form-data' target='gform_ajax_frame_4' id='gform_4'  action='/feed/#gf_4' data-formid='4' novalidate><div class='gf_invisible ginput_recaptchav3' data-sitekey='6LfM7dopAAAAAIHIkjsjjWCqKW8h87FYaRvTMFPU' data-tabindex='0'><input id="input_1c9cb9763a57953039690a5d3630d98b" class="gfield_recaptcha_response" type="hidden" name="input_1c9cb9763a57953039690a5d3630d98b" value=""/></div>
                        <div class='gform-body gform_body'><div id='gform_fields_4' class='gform_fields top_label form_sublabel_above description_above validation_above'><div id="field_4_1" class="gfield gfield--type-email gfield--input-type-email gfield--width-full field_sublabel_above gfield--no-description field_description_above field_validation_above gfield_visibility_visible"  ><label class='gfield_label gform-field-label' for='input_4_1'><span class='gform-field-label__text'>Email</span></label><div class='ginput_container ginput_container_email'>
                            <input name='input_1' id='input_4_1' type='email' value='' class='large'     aria-invalid="false"  />
                        </div></div><fieldset id="field_4_2" class="gfield gfield--type-consent gfield--type-choice gfield--input-type-consent gfield--width-full gfield_contains_required field_sublabel_above gfield--no-description field_description_above field_validation_above gfield_visibility_visible gfield--choice-align-vertical"  ><legend class='gfield_label gform-field-label gfield_label_before_complex' ><span class='gform-field-label__text'>Consent</span><span class="gfield_required"><span class="gfield_required gfield_required_text">(Required)</span></span></legend><div class='ginput_container ginput_container_consent'><input name='input_2.1' id='input_4_2_1' type='checkbox' value='1'   aria-required="true" aria-invalid="false"   /> <label class="gform-field-label gform-field-label--type-inline gfield_consent_label" for='input_4_2_1' ><span class='gform-field-label__text'>I’ve read the privacy policy and consent to Else Care (Carenity) processing my contact data only to provide the content requested.</span></label><input type='hidden' name='input_2.2' value='I’ve read the privacy policy and consent to Else Care (Carenity) processing my contact data only to provide the content requested.' class='gform_hidden' /><input type='hidden' name='input_2.3' value='3' class='gform_hidden' /></div></fieldset></div></div>
        <div class='gform-footer gform_footer top_label'> <button type='submit' id='gform_submit_button_4' class='gform_button button' onclick='gform.submission.handleButtonClick(this);' data-submission-type='submit' >Download</button> <input type='hidden' name='gform_ajax' value='form_id=4&amp;title=&amp;description=&amp;tabindex=0&amp;theme=gravity-theme&amp;styles=[]&amp;hash=1f43bae17c7444170f119f84c44d8f80' />
            <input type='hidden' class='gform_hidden' name='gform_submission_method' data-js='gform_submission_method_4' value='iframe' />
            <input type='hidden' class='gform_hidden' name='gform_theme' data-js='gform_theme_4' id='gform_theme_4' value='gravity-theme' />
            <input type='hidden' class='gform_hidden' name='gform_style_settings' data-js='gform_style_settings_4' id='gform_style_settings_4' value='[]' />
            <input type='hidden' class='gform_hidden' name='is_submit_4' value='1' />
            <input type='hidden' class='gform_hidden' name='gform_submit' value='4' />
            
            <input type='hidden' class='gform_hidden' name='gform_currency' data-currency='USD' value='W/oxJ8UeavoIwD7NbDR3mpX8GOlBdApPbeZLCKBC75W2dX7lFZnM44jcaFCTej8XKj/HJ8Z416vBEfIGxJSfjFJvEQliDhOOhEHErV0KCL7OzcQ=' />
            <input type='hidden' class='gform_hidden' name='gform_unique_id' value='' />
            <input type='hidden' class='gform_hidden' name='state_4' value='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' />
            <input type='hidden' autocomplete='off' class='gform_hidden' name='gform_target_page_number_4' id='gform_target_page_number_4' value='0' />
            <input type='hidden' autocomplete='off' class='gform_hidden' name='gform_source_page_number_4' id='gform_source_page_number_4' value='1' />
            <input type='hidden' name='gform_field_values' value='' />
            
        </div>
                        </form>
                        </div>
		                <iframe style='display:none;width:0px;height:0px;' src='about:blank' name='gform_ajax_frame_4' id='gform_ajax_frame_4' title='This iframe contains the logic required to handle Ajax powered Gravity Forms.'></iframe>
		                <script type="text/javascript">
/* <![CDATA[ */
 gform.initializeOnLoaded( function() {jQuery('#gform_ajax_frame_4').on('load',function(){var contents = jQuery(this).contents().find('*').html();var is_postback = contents.indexOf('GF_AJAX_POSTBACK') >= 0;if(!is_postback){return;}var form_content = jQuery(this).contents().find('#gform_wrapper_4');var is_confirmation = jQuery(this).contents().find('#gform_confirmation_wrapper_4').length > 0;var is_redirect = contents.indexOf('gformRedirect(){') >= 0;var is_form = form_content.length > 0 && ! is_redirect && ! is_confirmation;var mt = parseInt(jQuery('html').css('margin-top'), 10) + parseInt(jQuery('body').css('margin-top'), 10) + 100;if(is_form){jQuery('#gform_wrapper_4').html(form_content.html());if(form_content.hasClass('gform_validation_error')){jQuery('#gform_wrapper_4').addClass('gform_validation_error');} else {jQuery('#gform_wrapper_4').removeClass('gform_validation_error');}setTimeout( function() { /* delay the scroll by 50 milliseconds to fix a bug in chrome */ jQuery(document).scrollTop(1); }, 50 );var current_page = jQuery('#gform_source_page_number_4').val();jQuery(document).trigger('gform_page_loaded', [4, current_page]);window['gf_submitting_4'] = false;}else if(!is_redirect){var confirmation_content = jQuery(this).contents().find('.GF_AJAX_POSTBACK').html();if(!confirmation_content){confirmation_content = contents;}jQuery('#gform_wrapper_4').replaceWith(confirmation_content);jQuery(document).scrollTop(1);jQuery(document).trigger('gform_confirmation_loaded', [4]);window['gf_submitting_4'] = false;wp.a11y.speak(jQuery('#gform_confirmation_message_4').text());}else{jQuery('#gform_4').append(contents);if(window['gformRedirect']) {gformRedirect();}}jQuery(document).trigger("gform_pre_post_render", [{ formId: "4", currentPage: "current_page", abort: function() { this.preventDefault(); } }]);        if (event && event.defaultPrevented) {                return;        }        const gformWrapperDiv = document.getElementById( "gform_wrapper_4" );        if ( gformWrapperDiv ) {            const visibilitySpan = document.createElement( "span" );            visibilitySpan.id = "gform_visibility_test_4";            gformWrapperDiv.insertAdjacentElement( "afterend", visibilitySpan );        }        const visibilityTestDiv = document.getElementById( "gform_visibility_test_4" );        let postRenderFired = false;        function triggerPostRender() {            if ( postRenderFired ) {                return;            }            postRenderFired = true;            gform.core.triggerPostRenderEvents( 4, current_page );            if ( visibilityTestDiv ) {                visibilityTestDiv.parentNode.removeChild( visibilityTestDiv );            }        }        function debounce( func, wait, immediate ) {            var timeout;            return function() {                var context = this, args = arguments;                var later = function() {                    timeout = null;                    if ( !immediate ) func.apply( context, args );                };                var callNow = immediate && !timeout;                clearTimeout( timeout );                timeout = setTimeout( later, wait );                if ( callNow ) func.apply( context, args );            };        }        const debouncedTriggerPostRender = debounce( function() {            triggerPostRender();        }, 200 );        if ( visibilityTestDiv && visibilityTestDiv.offsetParent === null ) {            const observer = new MutationObserver( ( mutations ) => {                mutations.forEach( ( mutation ) => {                    if ( mutation.type === 'attributes' && visibilityTestDiv.offsetParent !== null ) {                        debouncedTriggerPostRender();                        observer.disconnect();                    }                });            });            observer.observe( document.body, {                attributes: true,                childList: false,                subtree: true,                attributeFilter: [ 'style', 'class' ],            });        } else {            triggerPostRender();        }    } );} ); 
/* ]]&gt; */
</script>
</div></div></div></div></div></div><div class="fusion-clearfix"></div></div></div></div></div><div class="fusion-fullwidth fullwidth-box fusion-builder-row-2 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="background-color: rgba(255,255,255,0);background-position: left top;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first" style="width:30.6666%; margin-right: 4%;margin-top:0px;margin-bottom:30px;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy" style="background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0 0 0 0;border-color:#dddddd;border-style:solid;padding: 0px 0px 0px 0px;"><div class="fusion-column-content-centered"><div class="fusion-column-content"></div></div><div class="fusion-clearfix"></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_3 1_3 fusion-one-third" style="width:30.6666%; margin-right: 4%;margin-top:0px;margin-bottom:30px;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy" style="background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0 0 0 0;border-color:#dddddd;border-style:solid;padding: 0px 0px 0px 0px;"><div class="fusion-column-content-centered"><div class="fusion-column-content"></div></div><div class="fusion-clearfix"></div></div></div></div></div></p>
<p>The post <a href="https://pro.carenity.com/2026/08/13/are-we-underestimating-the-true-cost-of-productivity-loss/">Are We Underestimating the True Cost of Productivity Loss?</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://pro.carenity.com/2026/08/13/are-we-underestimating-the-true-cost-of-productivity-loss/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Describing the burden of RSV infection and subsequent wheezing in toddlers: an international cross-sectional study</title>
		<link>https://pro.carenity.com/2026/01/16/describing-the-burden-of-rsv-infection-and-subsequent-wheezing-in-toddlers-an-international-cross-sectional-study-2/</link>
					<comments>https://pro.carenity.com/2026/01/16/describing-the-burden-of-rsv-infection-and-subsequent-wheezing-in-toddlers-an-international-cross-sectional-study-2/#respond</comments>
		
		<dc:creator><![CDATA[Asmae Moustansir]]></dc:creator>
		<pubDate>Fri, 16 Jan 2026 10:58:42 +0000</pubDate>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://pro.carenity.com/?p=25189</guid>

					<description><![CDATA[<p>Presented:EIP (2025)  Collaborator: Sanofi  Authors: Julie Laurent, Valentine Ficara, and Sahar Haidar    Respiratory syncytial virus (RSV) is one of the most common viral respiratory infections globally, with a rising incidence among children under five years of age. This study aimed to describe RSV and subsequent wheezing burden in toddlers ...</p>
<p>The post <a href="https://pro.carenity.com/2026/01/16/describing-the-burden-of-rsv-infection-and-subsequent-wheezing-in-toddlers-an-international-cross-sectional-study-2/">Describing the burden of RSV infection and subsequent wheezing in toddlers: an international cross-sectional study</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-3 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="background-color: rgba(255,255,255,0);background-position: left top;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last" style="margin-top:0px;margin-bottom:30px;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy" style="background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0 0 0 0;border-color:#dddddd;border-style:solid;padding: 0px 0px 0px 0px;"><div class="fusion-column-content-centered"><div class="fusion-column-content"><ul class="fusion-checklist fusion-checklist-1" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-newspaper far" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Presented:</strong>EIP (2025)</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-user fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Collaborator:</strong> Sanofi</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-users fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Authors:</strong> Julie Laurent, Valentine Ficara, and Sahar Haidar</p>
</div></li></ul><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:30px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-2"><p>Respiratory syncytial virus (RSV) is one of the most common viral respiratory infections globally, with a rising incidence among children under five years of age. This study aimed to describe RSV and subsequent wheezing burden in toddlers infected between the ages of 6 and 24 months and their parents.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:10px;width:100%;"></div><div class="fusion-sep-clear"></div><ul class="fusion-checklist fusion-checklist-2" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-no"><i class="fusion-li-icon fa-file-pdf far" style="color:#f01168;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><a href="https://cdn-membre.carenity.com/docs/RugoSABCS-2025-Final-SML-Carenity_Poster_21Nov2025-1765903609.pdf" target="_blank" rel="noopener">Read the original article</a></p>
</div></li></ul></div></div><div class="fusion-clearfix"></div></div></div></div></div>
<p>The post <a href="https://pro.carenity.com/2026/01/16/describing-the-burden-of-rsv-infection-and-subsequent-wheezing-in-toddlers-an-international-cross-sectional-study-2/">Describing the burden of RSV infection and subsequent wheezing in toddlers: an international cross-sectional study</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://pro.carenity.com/2026/01/16/describing-the-burden-of-rsv-infection-and-subsequent-wheezing-in-toddlers-an-international-cross-sectional-study-2/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>A real-world study to describe the effectiveness and usage patterns of hyoscine butylbromide plus tablets in patients with dysmenorrhoea</title>
		<link>https://pro.carenity.com/2026/01/02/a-real-world-study-to-describe-the-effectiveness-and-usage-patterns-of-hyoscine-butylbromide-plus-tablets-in-patients-with-dysmenorrhoea/</link>
					<comments>https://pro.carenity.com/2026/01/02/a-real-world-study-to-describe-the-effectiveness-and-usage-patterns-of-hyoscine-butylbromide-plus-tablets-in-patients-with-dysmenorrhoea/#respond</comments>
		
		<dc:creator><![CDATA[Asmae Moustansir]]></dc:creator>
		<pubDate>Fri, 02 Jan 2026 14:13:04 +0000</pubDate>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://pro.carenity.com/?p=25210</guid>

					<description><![CDATA[<p>Presented: Sage Journals (2026)  Collaborator: Sanofi  Authors: Robert Lange, Lorraine Harrington, Caroline Amand    Dysmenorrhoea, a common gynaecological issue in women, is characterised by lower abdominal cramps during menstruation impacting quality of life (QoL). This study evaluates the effectiveness, utilisation and safety of Buscopan® Plus (hyoscine butylbromide (HBB) Plus: 10 ...</p>
<p>The post <a href="https://pro.carenity.com/2026/01/02/a-real-world-study-to-describe-the-effectiveness-and-usage-patterns-of-hyoscine-butylbromide-plus-tablets-in-patients-with-dysmenorrhoea/">A real-world study to describe the effectiveness and usage patterns of hyoscine butylbromide plus tablets in patients with dysmenorrhoea</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-4 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="background-color: rgba(255,255,255,0);background-position: left top;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last" style="margin-top:0px;margin-bottom:30px;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy" style="background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0 0 0 0;border-color:#dddddd;border-style:solid;padding: 0px 0px 0px 0px;"><div class="fusion-column-content-centered"><div class="fusion-column-content"><ul class="fusion-checklist fusion-checklist-3" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-newspaper far" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Presented:</strong> Sage Journals (2026)</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-user fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Collaborator:</strong> Sanofi</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-users fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Authors: </strong>Robert Lange, Lorraine Harrington, Caroline Amand</p>
</div></li></ul><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:30px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-3"><p>Dysmenorrhoea, a common gynaecological issue in women, is characterised by lower abdominal cramps during menstruation impacting quality of life (QoL).</p>
<p>This study evaluates the effectiveness, utilisation and safety of Buscopan<sup>®</sup> Plus (hyoscine butylbromide (HBB) Plus: 10 mg HBB + 500 mg paracetamol) for self-treating menstrual pain.</p>
<p>This non-interventional, prospective cohort real-world study included women with menstrual pain registered with Carenity, an online patient platform by Else Care SAS.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:10px;width:100%;"></div><div class="fusion-sep-clear"></div><ul class="fusion-checklist fusion-checklist-4" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-no"><i class="fusion-li-icon fa-file-pdf far" style="color:#f01168;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><a href="https://journals.sagepub.com/doi/10.1177/17455057251406956" target="_blank" rel="noopener">Read the original article</a></p>
</div></li></ul></div></div><div class="fusion-clearfix"></div></div></div></div></div>
<p>The post <a href="https://pro.carenity.com/2026/01/02/a-real-world-study-to-describe-the-effectiveness-and-usage-patterns-of-hyoscine-butylbromide-plus-tablets-in-patients-with-dysmenorrhoea/">A real-world study to describe the effectiveness and usage patterns of hyoscine butylbromide plus tablets in patients with dysmenorrhoea</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://pro.carenity.com/2026/01/02/a-real-world-study-to-describe-the-effectiveness-and-usage-patterns-of-hyoscine-butylbromide-plus-tablets-in-patients-with-dysmenorrhoea/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Real-World Patient and Caregiver Experiences With Breast Cancer Risk of Recurrence in the US: Results of an Online Survey and Social Media Analysis</title>
		<link>https://pro.carenity.com/2025/12/16/real-world-patient-and-caregiver-experiences-with-breast-cancer-risk-of-recurrence-in-the-us-results-of-an-online-survey-and-social-media-analysis/</link>
					<comments>https://pro.carenity.com/2025/12/16/real-world-patient-and-caregiver-experiences-with-breast-cancer-risk-of-recurrence-in-the-us-results-of-an-online-survey-and-social-media-analysis/#respond</comments>
		
		<dc:creator><![CDATA[Asmae Moustansir]]></dc:creator>
		<pubDate>Tue, 16 Dec 2025 16:27:58 +0000</pubDate>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://pro.carenity.com/?p=25178</guid>

					<description><![CDATA[<p>Presented in SABCS – 2025  Collaborator: Novartis  Authors: Hope S. Rugo, Megan-Claire Chase, Megan Rutt, Mary Lou Smith, Sue Weldon, Emilie Pain, Gaurav Vadnerkar, Tamalika Sen, Shiva Padhi, Nimisha Nadimpalli, Liz Santarsiero, Corinth Auld, Nadia Harbeck, Anees B. Chagpar    Patients with hormone receptor–positive (HR+)/human epidermal growth factor receptor 2– ...</p>
<p>The post <a href="https://pro.carenity.com/2025/12/16/real-world-patient-and-caregiver-experiences-with-breast-cancer-risk-of-recurrence-in-the-us-results-of-an-online-survey-and-social-media-analysis/">Real-World Patient and Caregiver Experiences With Breast Cancer Risk of Recurrence in the US: Results of an Online Survey and Social Media Analysis</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-5 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="background-color: rgba(255,255,255,0);background-position: left top;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-5 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last" style="margin-top:0px;margin-bottom:30px;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy" style="background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0 0 0 0;border-color:#dddddd;border-style:solid;padding: 0px 0px 0px 0px;"><div class="fusion-column-content-centered"><div class="fusion-column-content"><ul class="fusion-checklist fusion-checklist-5" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-newspaper far" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Presented </strong>in SABCS – 2025</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-user fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Collaborator:</strong> Novartis</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-users fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Authors:</strong> Hope S. Rugo, Megan-Claire Chase, Megan Rutt, Mary Lou Smith, Sue Weldon, Emilie Pain, Gaurav Vadnerkar, Tamalika Sen, Shiva Padhi, Nimisha Nadimpalli, Liz Santarsiero, Corinth Auld, Nadia Harbeck, Anees B. Chagpar</p>
</div></li></ul><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:30px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-4"><p>Patients with hormone receptor–positive (HR+)/human epidermal growth factor receptor 2– negative (HER2−) early breast cancer (EBC) remain at risk of early (≤5 years) and late (&gt;5 years) disease recurrences despite standard-of-care adjuvant endocrine therapy.</p>
<p>Up to 27% of all patients with BC will recur within 10 years of diagnosis, particularly if initially diagnosed at stage II or III where recurrence rates are 41% and 63%, respectively. Currently, there is little published evidence related to the concerns of patients and caregivers concerning risk of recurrence (ROR). Lack of awareness about ROR has considerable impact on patient and caregiver quality of life, which may result in emotional distress from being unprepared about the true ROR.<br />
Here, we present important insights on ROR through the combined results of an online patient survey and subsequent social media analysis (SMA) of patients and caregivers.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:10px;width:100%;"></div><div class="fusion-sep-clear"></div><ul class="fusion-checklist fusion-checklist-6" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-no"><i class="fusion-li-icon fa-file-pdf far" style="color:#f01168;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><a href="https://cdn-membre.carenity.com/docs/RugoSABCS-2025-Final-SML-Carenity_Poster_21Nov2025-1765903609.pdf" target="_blank" rel="noopener">Read the original article</a></p>
</div></li></ul></div></div><div class="fusion-clearfix"></div></div></div></div></div>
<p>The post <a href="https://pro.carenity.com/2025/12/16/real-world-patient-and-caregiver-experiences-with-breast-cancer-risk-of-recurrence-in-the-us-results-of-an-online-survey-and-social-media-analysis/">Real-World Patient and Caregiver Experiences With Breast Cancer Risk of Recurrence in the US: Results of an Online Survey and Social Media Analysis</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://pro.carenity.com/2025/12/16/real-world-patient-and-caregiver-experiences-with-breast-cancer-risk-of-recurrence-in-the-us-results-of-an-online-survey-and-social-media-analysis/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Understanding the Burden of Myocardial Infarction and Patient Preferences for Treatment: A Real-World Study Assessing Patients’ Perspectives via an Online Survey</title>
		<link>https://pro.carenity.com/2025/09/30/understanding-the-burden-of-myocardial-infarction-and-patient-preferences-for-treatment-a-real-world-study-assessing-patients-perspectives-via-an-online-survey/</link>
					<comments>https://pro.carenity.com/2025/09/30/understanding-the-burden-of-myocardial-infarction-and-patient-preferences-for-treatment-a-real-world-study-assessing-patients-perspectives-via-an-online-survey/#respond</comments>
		
		<dc:creator><![CDATA[Asmae Moustansir]]></dc:creator>
		<pubDate>Tue, 30 Sep 2025 14:48:33 +0000</pubDate>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://pro.carenity.com/?p=25216</guid>

					<description><![CDATA[<p>Presented: ADVOCATE HEALTH (2025)  Collaborator: CSL Behring  Authors: :  Cecilia Bahit, Serge Korjian, Gerald Chi, Yazan Daaboul, Alberto Castro Molina, Ginger Jiang, Christiana Dangas, Mudit Tandon, Deepak L. Bhatt, Roxana Mehran, Harriette G.C. van Spall, Paul Nara, Alka Shaunik, Charles Michael Gibson    Purpose: Myocardial infarction (MI) remains to be ...</p>
<p>The post <a href="https://pro.carenity.com/2025/09/30/understanding-the-burden-of-myocardial-infarction-and-patient-preferences-for-treatment-a-real-world-study-assessing-patients-perspectives-via-an-online-survey/">Understanding the Burden of Myocardial Infarction and Patient Preferences for Treatment: A Real-World Study Assessing Patients’ Perspectives via an Online Survey</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-6 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="background-color: rgba(255,255,255,0);background-position: left top;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-6 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last" style="margin-top:0px;margin-bottom:30px;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy" style="background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0 0 0 0;border-color:#dddddd;border-style:solid;padding: 0px 0px 0px 0px;"><div class="fusion-column-content-centered"><div class="fusion-column-content"><ul class="fusion-checklist fusion-checklist-7" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-newspaper far" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Presented: </strong>ADVOCATE HEALTH (2025)</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-user fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Collaborator:</strong> CSL Behring</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-users fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Authors:</strong> <u>:</u>  Cecilia Bahit, Serge Korjian, Gerald Chi, Yazan Daaboul, Alberto Castro Molina, Ginger Jiang, Christiana Dangas, Mudit Tandon, Deepak L. Bhatt, Roxana Mehran, Harriette G.C. van Spall, Paul Nara, Alka Shaunik, Charles Michael Gibson</p>
</div></li></ul><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:30px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-5"><p><strong>Purpose</strong>: Myocardial infarction (MI) remains to be associated with a high risk of recurrent cardiovascular events and disease burden. This study assessed patient perspectives on the burden of disease and treatment in the first year post-MI.</p>
<p><strong>Methods</strong>: Data were collected via a self-administered online questionnaire posted on the Carenity patient platform in the United States (10/30/2022−12/30/2022). Only patients who had an MI in the prior year were eligible for inclusion.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:10px;width:100%;"></div><div class="fusion-sep-clear"></div><ul class="fusion-checklist fusion-checklist-8" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-no"><i class="fusion-li-icon fa-file-pdf far" style="color:#f01168;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><a href="https://cdn-membre.carenity.com/docs/RugoSABCS-2025-Final-SML-Carenity_Poster_21Nov2025-1765903609.pdf" target="_blank" rel="noopener">Read the original article</a></p>
</div></li></ul></div></div><div class="fusion-clearfix"></div></div></div></div></div>
<p>The post <a href="https://pro.carenity.com/2025/09/30/understanding-the-burden-of-myocardial-infarction-and-patient-preferences-for-treatment-a-real-world-study-assessing-patients-perspectives-via-an-online-survey/">Understanding the Burden of Myocardial Infarction and Patient Preferences for Treatment: A Real-World Study Assessing Patients’ Perspectives via an Online Survey</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://pro.carenity.com/2025/09/30/understanding-the-burden-of-myocardial-infarction-and-patient-preferences-for-treatment-a-real-world-study-assessing-patients-perspectives-via-an-online-survey/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Describing the burden of RSV infection and subsequent wheezing in toddlers: an international cross-sectional study</title>
		<link>https://pro.carenity.com/2025/09/28/describing-the-burden-of-rsv-infection-and-subsequent-wheezing-in-toddlers-an-international-cross-sectional-study/</link>
					<comments>https://pro.carenity.com/2025/09/28/describing-the-burden-of-rsv-infection-and-subsequent-wheezing-in-toddlers-an-international-cross-sectional-study/#respond</comments>
		
		<dc:creator><![CDATA[Asmae Moustansir]]></dc:creator>
		<pubDate>Sun, 28 Sep 2025 14:43:47 +0000</pubDate>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://pro.carenity.com/?p=25147</guid>

					<description><![CDATA[<p>Presented in ERS – 2025  Collaborator: Sanofi  Authors: Julie Laurent, Valentine Ficara, Sahar Haidar    Respiratory syncytial virus (RSV) is a leading cause of respiratory tract infection in children. This study aimed to describe RSV and subsequent wheezing burden in toddlers aged 6 to 24 months and their parents.   ...</p>
<p>The post <a href="https://pro.carenity.com/2025/09/28/describing-the-burden-of-rsv-infection-and-subsequent-wheezing-in-toddlers-an-international-cross-sectional-study/">Describing the burden of RSV infection and subsequent wheezing in toddlers: an international cross-sectional study</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-7 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="background-color: rgba(255,255,255,0);background-position: left top;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-7 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last" style="margin-top:0px;margin-bottom:30px;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy" style="background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0 0 0 0;border-color:#dddddd;border-style:solid;padding: 0px 0px 0px 0px;"><div class="fusion-column-content-centered"><div class="fusion-column-content"><ul class="fusion-checklist fusion-checklist-9" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-newspaper far" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Presented </strong>in ERS – 2025</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-user fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Collaborator:</strong> Sanofi</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-users fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Authors:</strong> Julie Laurent, Valentine Ficara, Sahar Haidar</p>
</div></li></ul><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:30px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-6"><p>Respiratory syncytial virus (RSV) is a leading cause of respiratory tract infection in children. This study aimed to describe RSV and subsequent wheezing burden in toddlers aged 6 to 24 months and their parents.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:10px;width:100%;"></div><div class="fusion-sep-clear"></div><ul class="fusion-checklist fusion-checklist-10" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-no"><i class="fusion-li-icon fa-file-pdf far" style="color:#f01168;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><a href="https://cdn-membre.carenity.com/docs/POSTER_RSV_-TODDLERS_Final-1759500670.pdf" target="_blank" rel="noopener">Read the original article</a></p>
</div></li></ul></div></div><div class="fusion-clearfix"></div></div></div></div></div>
<p>The post <a href="https://pro.carenity.com/2025/09/28/describing-the-burden-of-rsv-infection-and-subsequent-wheezing-in-toddlers-an-international-cross-sectional-study/">Describing the burden of RSV infection and subsequent wheezing in toddlers: an international cross-sectional study</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://pro.carenity.com/2025/09/28/describing-the-burden-of-rsv-infection-and-subsequent-wheezing-in-toddlers-an-international-cross-sectional-study/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>A discrete choice experiment analysis to understand patient preferences for multiple myeloma treatments</title>
		<link>https://pro.carenity.com/2025/09/16/a-discrete-choice-experiment-analysis-to-understand-patient-preferences-for-multiple-myeloma-treatments/</link>
					<comments>https://pro.carenity.com/2025/09/16/a-discrete-choice-experiment-analysis-to-understand-patient-preferences-for-multiple-myeloma-treatments/#respond</comments>
		
		<dc:creator><![CDATA[Asmae Moustansir]]></dc:creator>
		<pubDate>Tue, 16 Sep 2025 14:41:23 +0000</pubDate>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://pro.carenity.com/?p=25136</guid>

					<description><![CDATA[<p>Published in Frontiers in Oncology – 2025  Collaborator: Johnson &amp; Johnson  Authors: Beth Faiman, Hoa H. Le, Julie Laurent, Saurabh Patel, Agne Paner-Straseviciute, Xinke Zhang, Joseph Mikhae    Multiple myeloma (MM) is a malignant plasma cell disorder characterized by the clonal expansion of abnormal plasma cells within the bone marrow. The ...</p>
<p>The post <a href="https://pro.carenity.com/2025/09/16/a-discrete-choice-experiment-analysis-to-understand-patient-preferences-for-multiple-myeloma-treatments/">A discrete choice experiment analysis to understand patient preferences for multiple myeloma treatments</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-8 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="background-color: rgba(255,255,255,0);background-position: left top;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-8 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last" style="margin-top:0px;margin-bottom:30px;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy" style="background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0 0 0 0;border-color:#dddddd;border-style:solid;padding: 0px 0px 0px 0px;"><div class="fusion-column-content-centered"><div class="fusion-column-content"><ul class="fusion-checklist fusion-checklist-11" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-newspaper far" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Published</strong> in Frontiers in Oncology – 2025</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-user fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Collaborator:</strong> Johnson &amp; Johnson</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-users fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Authors:</strong> Beth Faiman, Hoa H. Le, Julie Laurent, Saurabh Patel, Agne Paner-Straseviciute, Xinke<br />
Zhang, Joseph Mikhae</p>
</div></li></ul><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:30px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-7"><p>Multiple myeloma (MM) is a malignant plasma cell disorder characterized by the clonal expansion of abnormal plasma cells within the bone marrow. The management of relapsed/refractory multiple myeloma (RRMM) represents a significant challenge as the disease relapses or becomes<br />
refractory to previous treatments. Recent advances in therapy have expanded RRMM treatment options. This study aimed to gain a deeper understanding of patients&#8217; treatment preferences regarding available therapeutic options.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:10px;width:100%;"></div><div class="fusion-sep-clear"></div><ul class="fusion-checklist fusion-checklist-12" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-no"><i class="fusion-li-icon fa-file-pdf far" style="color:#f01168;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><a href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1628121/full" target="_blank" rel="noopener">Read the original article</a></p>
</div></li></ul></div></div><div class="fusion-clearfix"></div></div></div></div></div>
<p>The post <a href="https://pro.carenity.com/2025/09/16/a-discrete-choice-experiment-analysis-to-understand-patient-preferences-for-multiple-myeloma-treatments/">A discrete choice experiment analysis to understand patient preferences for multiple myeloma treatments</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://pro.carenity.com/2025/09/16/a-discrete-choice-experiment-analysis-to-understand-patient-preferences-for-multiple-myeloma-treatments/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Patient survey in immune thrombocytopenia (ITP): Identifying unmet needs related to treatment and disease control in patients living in the United States</title>
		<link>https://pro.carenity.com/2025/08/17/evaluating-digital-health-solutions-in-diabetes-and-the-role-of-patient-reported-outcomes-targeted-literature-review-2/</link>
					<comments>https://pro.carenity.com/2025/08/17/evaluating-digital-health-solutions-in-diabetes-and-the-role-of-patient-reported-outcomes-targeted-literature-review-2/#respond</comments>
		
		<dc:creator><![CDATA[Asmae Moustansir]]></dc:creator>
		<pubDate>Sun, 17 Aug 2025 13:30:47 +0000</pubDate>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://pro.carenity.com/?p=25074</guid>

					<description><![CDATA[<p>Published in British Journal of Haematology (2025)  Collaborator: Sanofi  Authors: Nichola Cooper, Caroline Kruse, Sharon Deneen Morgan, Julie Laurent, Marleni Arvelo- Saillant, Jean-Pascal Roussy, Matias Cordoba, Imene Gouia, Lisa-Anne Schmitt, Erin Reineke, Terry Gernsheimer    Immune thrombocytopenia (ITP) is a chronic disease with primary therapeutic goals of platelet count recovery ...</p>
<p>The post <a href="https://pro.carenity.com/2025/08/17/evaluating-digital-health-solutions-in-diabetes-and-the-role-of-patient-reported-outcomes-targeted-literature-review-2/">Patient survey in immune thrombocytopenia (ITP): Identifying unmet needs related to treatment and disease control in patients living in the United States</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-9 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="background-color: rgba(255,255,255,0);background-position: left top;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-9 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last" style="margin-top:0px;margin-bottom:30px;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy" style="background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0 0 0 0;border-color:#dddddd;border-style:solid;padding: 0px 0px 0px 0px;"><div class="fusion-column-content-centered"><div class="fusion-column-content"><ul class="fusion-checklist fusion-checklist-13" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-newspaper far" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Published</strong> in British Journal of Haematology (2025)</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-user fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Collaborator:</strong> Sanofi</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-users fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Authors:</strong> Nichola Cooper, Caroline Kruse, Sharon Deneen Morgan, Julie Laurent, Marleni Arvelo-<br />
Saillant, Jean-Pascal Roussy, Matias Cordoba, Imene Gouia, Lisa-Anne Schmitt, Erin Reineke, Terry<br />
Gernsheimer</p>
</div></li></ul><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:30px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-8"><p>Immune thrombocytopenia (ITP) is a chronic disease with primary therapeutic goals of platelet<br />
count recovery to safe levels to minimize active/future bleeding, alongside easing additional<br />
symptoms negatively impacting overall patient well-being with consequent improvement in<br />
physical fatigue/energy levels, daily/work-related activities and social/emotional health.<br />
Documentation of this rare disease is important for evaluating real-world experiences in treatment<br />
satisfaction, expectations and unmet needs in disease management.<br />
This study examined patient experiences and preferences, treatment satisfaction and expectations<br />
and unmet patient needs related to disease management and control based on the outcomes of a<br />
survey conducted in adults with ITP.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:10px;width:100%;"></div><div class="fusion-sep-clear"></div><ul class="fusion-checklist fusion-checklist-14" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-no"><i class="fusion-li-icon fa-file-pdf far" style="color:#f01168;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><a href="https://onlinelibrary.wiley.com/doi/10.1111/bjh.20257" target="_blank" rel="noopener">Read the original article</a></p>
</div></li></ul></div></div><div class="fusion-clearfix"></div></div></div></div></div>
<p>The post <a href="https://pro.carenity.com/2025/08/17/evaluating-digital-health-solutions-in-diabetes-and-the-role-of-patient-reported-outcomes-targeted-literature-review-2/">Patient survey in immune thrombocytopenia (ITP): Identifying unmet needs related to treatment and disease control in patients living in the United States</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://pro.carenity.com/2025/08/17/evaluating-digital-health-solutions-in-diabetes-and-the-role-of-patient-reported-outcomes-targeted-literature-review-2/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Perceptions of use and value for different types of digital health solutions among people with type 1 and 2 diabetes in France</title>
		<link>https://pro.carenity.com/2025/08/08/perceptions-of-use-and-value-for-different-types-of-digital-health-solutions-among-people-with-type-1-and-2-diabetes-in-france/</link>
					<comments>https://pro.carenity.com/2025/08/08/perceptions-of-use-and-value-for-different-types-of-digital-health-solutions-among-people-with-type-1-and-2-diabetes-in-france/#respond</comments>
		
		<dc:creator><![CDATA[Asmae Moustansir]]></dc:creator>
		<pubDate>Fri, 08 Aug 2025 13:11:15 +0000</pubDate>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://pro.carenity.com/?p=25073</guid>

					<description><![CDATA[<p>Published in Acta Diabetologica (2025)  Collaborator: Roche  Authors: Norbert Hermanns, Paco Cerletti, Julie Laurent, Renza Scibilia, Sören Skovlund    This study examines the use, perceptions, and inequalities in access to Digital Health Solutions (DHS) among people with diabetes (PwD). It aims to identify factors influencing adoption and explore perceived benefits ...</p>
<p>The post <a href="https://pro.carenity.com/2025/08/08/perceptions-of-use-and-value-for-different-types-of-digital-health-solutions-among-people-with-type-1-and-2-diabetes-in-france/">Perceptions of use and value for different types of digital health solutions among people with type 1 and 2 diabetes in France</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-10 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="background-color: rgba(255,255,255,0);background-position: left top;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-10 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last" style="margin-top:0px;margin-bottom:30px;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy" style="background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0 0 0 0;border-color:#dddddd;border-style:solid;padding: 0px 0px 0px 0px;"><div class="fusion-column-content-centered"><div class="fusion-column-content"><ul class="fusion-checklist fusion-checklist-15" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-newspaper far" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Published</strong> in Acta Diabetologica (2025)</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-user fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Collaborator:</strong> Roche</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-users fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Authors:</strong> Norbert Hermanns, Paco Cerletti, Julie Laurent, Renza Scibilia, Sören Skovlund</p>
</div></li></ul><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:30px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-9"><p>This study examines the use, perceptions, and inequalities in access to Digital Health Solutions (DHS) among people with diabetes (PwD). It aims to identify factors influencing adoption and explore perceived benefits and barriers to using DHS, focusing on person-important outcomes such as physical health, mental burden, and access to care.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:10px;width:100%;"></div><div class="fusion-sep-clear"></div><ul class="fusion-checklist fusion-checklist-16" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-no"><i class="fusion-li-icon fa-file-pdf far" style="color:#f01168;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><a href="https://link.springer.com/article/10.1007/s00592-025-02564-6" target="_blank" rel="noopener">Read the original article</a></p>
</div></li></ul></div></div><div class="fusion-clearfix"></div></div></div></div></div>
<p>The post <a href="https://pro.carenity.com/2025/08/08/perceptions-of-use-and-value-for-different-types-of-digital-health-solutions-among-people-with-type-1-and-2-diabetes-in-france/">Perceptions of use and value for different types of digital health solutions among people with type 1 and 2 diabetes in France</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://pro.carenity.com/2025/08/08/perceptions-of-use-and-value-for-different-types-of-digital-health-solutions-among-people-with-type-1-and-2-diabetes-in-france/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Patient Perspectives on the Lifelong Impact of Preterm Birth in Chronic Respiratory Disease Care</title>
		<link>https://pro.carenity.com/2025/07/03/patient-perspectives-on-the-lifelong-impact-of-preterm-birth-in-chronic-respiratory-disease-care/</link>
					<comments>https://pro.carenity.com/2025/07/03/patient-perspectives-on-the-lifelong-impact-of-preterm-birth-in-chronic-respiratory-disease-care/#respond</comments>
		
		<dc:creator><![CDATA[Asmae Moustansir]]></dc:creator>
		<pubDate>Thu, 03 Jul 2025 13:15:01 +0000</pubDate>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://pro.carenity.com/?p=25128</guid>

					<description><![CDATA[<p>Presented at DSVR (2025)  Collaborator: Chiesi  Authors: Valentine Ficara, Emilie Pain, Cynthia Lesbros    Approximately 15 million infants are born prematurely each year. Preterm status is often associated with lifelong chronic respiratory conditions, such as asthma and Chronic Obstructive Pulmonary Disease (COPD) [2]. Data on prematurity impact on respiratory disease ...</p>
<p>The post <a href="https://pro.carenity.com/2025/07/03/patient-perspectives-on-the-lifelong-impact-of-preterm-birth-in-chronic-respiratory-disease-care/">Patient Perspectives on the Lifelong Impact of Preterm Birth in Chronic Respiratory Disease Care</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-11 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="background-color: rgba(255,255,255,0);background-position: left top;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-11 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last" style="margin-top:0px;margin-bottom:30px;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy" style="background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0 0 0 0;border-color:#dddddd;border-style:solid;padding: 0px 0px 0px 0px;"><div class="fusion-column-content-centered"><div class="fusion-column-content"><ul class="fusion-checklist fusion-checklist-17" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-newspaper far" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Presented at </strong>DSVR (2025)</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-user far" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Collaborator: </strong>Chiesi</p>
</div></li><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="background-color:#14ccad;font-size:15.84px;height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-yes"><i class="fusion-li-icon fa-users fas" style="color:#ffffff;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><strong>Authors:</strong> Valentine Ficara, Emilie Pain, Cynthia Lesbros</p>
</div></li></ul><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:30px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-10"><p>Approximately 15 million infants are born prematurely each year. Preterm status is often associated with lifelong chronic respiratory conditions, such as asthma and Chronic Obstructive Pulmonary Disease (COPD) [2]. Data on prematurity impact on respiratory disease progression and management in adulthood remain limited. This study aims to investigate patient awareness of their preterm status, its perceived impact on their respiratory health, and how healthcare professionals<br />
(HCPs) consider preterm status when managing these conditions.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:10px;width:100%;"></div><div class="fusion-sep-clear"></div><ul class="fusion-checklist fusion-checklist-18" style="font-size:18px;line-height:30.6px;"><li style="background-color:rgba(255,255,255,0);" class="fusion-li-item"><span style="height:30.6px;width:30.6px;margin-right:12.6px;" class="icon-wrapper circle-no"><i class="fusion-li-icon fa-file-pdf far" style="color:#f01168;" aria-hidden="true"></i></span><div class="fusion-li-item-content" style="margin-left:43.2px;color:#7e8890;">
<p><a href="https://cdn-membre.carenity.com/docs/Poster_Chiesi_DSVR_V3-1751665404.pdf" target="_blank" rel="noopener">Access to the poster</a></p>
</div></li></ul></div></div><div class="fusion-clearfix"></div></div></div></div></div>
<p>The post <a href="https://pro.carenity.com/2025/07/03/patient-perspectives-on-the-lifelong-impact-of-preterm-birth-in-chronic-respiratory-disease-care/">Patient Perspectives on the Lifelong Impact of Preterm Birth in Chronic Respiratory Disease Care</a> appeared first on <a href="https://pro.carenity.com">Carenity Pro</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://pro.carenity.com/2025/07/03/patient-perspectives-on-the-lifelong-impact-of-preterm-birth-in-chronic-respiratory-disease-care/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
